Cinnamon Extract Prevents the Insulin Resistance Induced by a High-fructose Diet

Abstract

The aim of this study was to determine whether cinnamon extract (CE) would improve the glucose utilization in normal male Wistar rats fed a high-fructose diet (HFD) for three weeks with or without CE added to the drinking water (300 mg/kg/day). In vivo glucose utilization was measured by the euglycemic clamp technique. Further analyses on the possible changes in insulin signaling occurring in skeletal muscle were performed afterwards by Western blotting. At 3 mU/kg/min insulin infusions, the decreased glucose infusion rate (GIR) in HFD-fed rats (60 % of controls, p < 0.01) was improved by CE administration to the same level of controls (normal chow diet) and the improving effect of CE on the GIR of HFD-fed rats was blocked by approximately 50 % by N-monometyl-L-arginine. The same tendency was found during the 30 mU/kg/min insulin infusions. There were no differences in skeletal muscle insulin receptor (IR)-β, IR substrate (IRS)-1, or phosphatidylinositol (PI) 3-kinase protein content in any groups. However, the muscular insulin-stimulated IR-β and IRS-1 tyrosine phosphorylation levels and IRS-1 associated with PI 3-kinase in HFD-fed rats were only 70 ± 9 %, 76 ± 5 %, and 72 ± 6 % of controls (p < 0.05), respectively, and these decreases were significantly improved by CE treatment. These results suggest that early CE administration to HFD-fed rats would prevent the development of insulin resistance at least in part by enhancing insulin signaling and possibly via the NO pathway in skeletal muscle.

Key words

Traditional herbal medicine - Insulin action - Nitric oxide - Insulin signaling

References

• 1 Annual Change of Intake of Foods by Food Groups. The present condition of national nutrition (Japan). 2000: 134-137
• 2 Elliott S S, Keim N L, Stern J S, Teff K, Havel P J. Fructose, weight gain, and the insulin resistance syndrome.  Am J Clin Nutr. 2002;  76 911-922
• 3 Hamman R F. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM).  Diabetes Metab Rev. 1992;  8 287-338
• 4 Kahn C R. Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction.  Metabolism. 1978;  27 1893-1902
• 5 Beck-Nielsen H, Pedersen O, Lindskov H O. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects.  Am J Clin Nutr. 1980;  33 273-278
• 6 Hallfrisch J. et al . Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men.  J Nutr. 1983;  113 1819-1826
• 7 Hwang I S, Ho H, Hoffman B B, Reaven G M. Fructose-induced insulin resistance and hypertension in rats.  Hypertension. 1987;  10 512-516
• 8 Ueno M. et al . A high-fructose diet induces changes in pp185 phosphorylation in muscle and liver of rats.  Braz J Med Biol Res. 2000;  33 1421-1427
• 9 Bezerra R M. et al . A high fructose diet affects the early steps of insulin action in muscle and liver of rats.  J Nutr. 2000;  130 1531-1535
• 10 Lee M K. et al . Metabolic effects of troglitazone on fructose-induced insulin resistance in the rat.  Diabetes. 1994;  43 1435-1439
• 11 Nikkila E A, Ojala K. Induction of hyperglyceridemia by fructose in the rat.  Life Sci. 1965;  4 937-943
• 12 Thorburn A W, Storlien L H, Jenkins A B, Khouri S, Kraegen E W. Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats.  Am J Clin Nutr. 1989;  49 1155-1163
• 13 Toriizuka K. Basic lecture of Kampo medicine: Pharmacological effect of cinnamon.  Kampo medicine. 1998;  11 431-436
• 14 Broadhurst C L, Polansky M M, Anderson R A. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro.  J Agric Food Chem. 2000;  48 849-852
• 15 Khan A, Bryden N A, Polansky M M, Anderson R A. Insulin potentiating factor and chromium content of selected foods and spices.  Biol Trace Elem Res. 1990;  24 183-188
• 16 Imparl-Radosevich J. et al . Regulation of PTP-1 and insulin receptor kinase by fractions from cinnamon: implications for cinnamon regulation of insulin signalling.  Horm Res. 1998;  50 177-182
• 17 Jarvill-Taylor K J, Anderson R A, Graves D J. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes.  J Am Coll Nutr. 2001;  20 327-336
• 18 Qin B. et al . Cinnamon extract (Traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats.  Diabetes Res Clin Pract. 2003;  62 139-148
• 19 Hu X. et al . Effect of Gosha-jinki-gan (Chinese herbal medicine: Niu-Che-Sen-Qi-Wan) on insulin resistance in streptozotocin-induced diabetic rats.  Diabetes Res Clin Pract. 2003;  59 103-111
• 20 Qin B. et al . Effects of Keishi-ka-jutsubu-to (traditional herbal medicine: Gui-zhi-jia-shu-fu-tang), on in vivo insulin action in streptozotocin-induced diabetic rats.  Life Sciences. 2003;  73 2687-2701
• 21 Kashiwagi A. et al . Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state.  Diabetes Res Clin Pract. 1999;  45 199-203
• 22 Shinozaki K. et al . Abnormal biopterin metabolism is a major cause of impaired endothelium-dependent relaxation through nitric oxide/O₂-imbalance in insulin-resistant rat aorta.  Diabetes. 1999;  48 2437-2445
• 23 Damiano P. et al . Impaired response to insulin associated with protein kinase C in chronic fructose-induced hypertension.  Blood Press. 2002;  11 345-351
• 24 Oshida Y. et al . Nitric oxide decreases insulin resistance induced by high-fructose feeding.  Horm Metab Res. 2000;  32 339-342
• 25 DeFronzo R A, Bonadonna R C, Ferrannini E. Pathogenesis of NIDDM. A balanced overview.  Diabetes Care. 1992;  15 318-368
• 26 DeFronzo R A. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.  Diabetes. 1988;  37 667-687
• 27 Gardiner S M, Kemp P A, March J E, Bennett T. Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.  Br J Pharm. 1995;  116 2005-2016
• 28 Nagasaki M. et al . Exercise training prevents maturation-induced decreases in insulin receptor substrate-1 and phosphatidylinositol 3-kinase in rat skeletal muscle.  Metabolism. 2000;  49 954-959
• 29 Goodyear L J. et al . Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.  J Clin Invest. 1995;  95 2195-2204
• 30 Olefsky J, Kolterman O, Scarlett J. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus.  American Journal of Physiology. 1999;  243 E15-30
• 31 Cardillo C. et al . Insulin stimulates both endothelin and nitric oxide activity in the human forearm.  Circulation. 1999;  100 820-825
• 32 Petrie J R, Ueda S, Webb D J, Elliott H L, Connell J M. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease.  Circulation. 1996;  93 1331-1333
• 33 Balon T W, Nadler J L. Evidence that nitric oxide increases glucose transport in skeletal muscle.  J Appl Physiol. 1997;  82 359-363
• 34 Etgen G J Jr, Fryburg D A, Gibbs E M. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway.  Diabetes. 1997;  46 1915-1919
• 35 Roy D, Perreault M, Marette A. Insulin stimulation of glucose uptake in skeletal muscles and adipose tissues in vivo is NO dependent.  American Journal of Physiology. 1998;  274 E692-699
• 36 Shankar R. et al . Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.  Journal of Clinical Investigation. 1998;  102 1403-1412
• 37 Li L. et al . Role of nitric oxide in insulin action in STZ-induced diabetic rats - use of euglycaemic clamp technique.  The Journal of Japan Diabetes Society. 2000;  43 301-306
• 38 Smith D. et al . In vivo glucose metabolism in the awake rat: tracer and insulin clamp studies.  Metabolism. 1987;  36 1167-1174
• 39 Montagnani M, Ravichandran L, Chen H, Esposito D, Quon M. Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells.  Molecular Endocrinology. 2002;  16 1931-1942
• 40 Zeng G. et al . Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells.  Circulation. 2000;  101 1539-1545
• 41 Zeng G, Quon M J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.  J Clin Invest. 1996;  98 894-898
• 42 Montagnani M, Chen H, Barr V A, Quon M J. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser (1179).  J Biol Chem. 2001;  276 30 392-30 398
• 43 Zeng G, Quon M J. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells.  Journal of Clinical Investigation. 1996;  98 894-898
• 44 DeFronzo R A. et al . The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization.  Diabetes. 1981;  30 1000-1007
• 45 DeFronzo R A, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulin-dependent (type II) diabetes mellitus.  J Clin Invest. 1985;  76 149-155
• 46 Handberg A, Vaag A, Vinten J, Beck-Nielsen H. Decreased tyrosine kinase activity in partially purified insulin receptors from muscle of young, non-obese first degree relatives of patients with type 2 (non-insulin-dependent) diabetes mellitus.  Diabetologia. 1993;  36 668-674
• 47 Pratipanawatr W. et al . Skeletal muscle insulin resistance in normoglycemic subjects with a strong family history of type 2 diabetes is associated with decreased insulin-stimulated insulin receptor substrate-1 tyrosine phosphorylation.  Diabetes. 2001;  50 2572-2578
• 48 Storgaard H. et al . Insulin signal transduction in skeletal muscle from glucose-intolerant relatives of type 2 diabetic patients [corrected].  Diabetes. 2001;  50 2770-2778
• 49 Cusi K. et al . Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.  J Clin Invest. 2000;  105 311-320
• 50 Cheatham B. et al . Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation.  Mol Cell Biol. 1994;  14 4902-4911
• 51 Okada T, Kawano Y, Sakakibara T, Hazeki O, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin.  J Biol Chem. 1994;  269 3568-3573
• 52 Folli F, Saad M J, Backer J M, Kahn C R. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus.  J Clin Invest. 1993;  92 1787-1794